NEUROCHEM INTERNAT LTD has a total of 15 patent applications. Its first patent ever was published in 2000. It filed its patents most often in China and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are SHIN POONG PHARMACEUTICAL CO LTD, WIGEN BIOMEDICINE TECH SHANGHAI CO LTD and HUBEI BIO-PHARMACEUTICAL IND TECH INST INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 12 | |
#2 | Republic of Korea | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Peptides | |
#5 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Francine Gervais | 4 |
#2 | Xinfu Wu | 4 |
#3 | Isabelle Valade | 3 |
#4 | Francesco Bellini | 3 |
#5 | Xianqi Kong | 3 |
#6 | David Migneault | 3 |
#7 | Kong Xianqi | 2 |
#8 | Gervais Francine | 2 |
#9 | Abderrahim Bouzide | 2 |
#10 | Denis Garceau | 1 |
Publication | Filing date | Title |
---|---|---|
CN101193628A | Pharmaceutical formulations of amyloid inhibiting compounds | |
CN101103018A | Compounds for the treatment of CNS and amyloid associated diseases | |
CN101124200A | Methods and fluorinated compositions for treating amyloid-related diseases | |
CN1882375A | Treatment of amyloid- and epileptogenesis-associated diseases | |
CN1838950A | Methods for treating protein aggregation disorders | |
CN1838946A | Pharmaceutical formulations of amyloid inhibiting compounds | |
CN1839117A | Improved drug and its preparing method | |
CN1753662A | Therapeutic formulations for the treatment of beta-amyloid related diseases |